| Not Yet Recruiting | Cultivated Limbal Epithelial Transplantation (CLET) for Limbal Stem Cell Deficiency (LSCD) NCT03884569 | Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA | — |
| Recruiting | Association Between Limbal Function and Tear Proteomics in Chronic Ocular Diseases: Focusing on Glaucoma NCT07119580 | National Taiwan University Hospital | — |
| Recruiting | Implementation of a Protocol for the Transdifferentiation of Buccal Mucosal Epithelium Into Corneal Epithelium NCT06265298 | University Hospital, Montpellier | N/A |
| Recruiting | Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Subjects With Limbal Stem Cel NCT06452316 | Claris Biotherapeutics, Inc. | Phase 1 |
| Not Yet Recruiting | Validation of Human Drugs Target of Repurposed Drugs and Novel Therapies NCT06412718 | IRCCS Ospedale San Raffaele | — |
| Completed | Treatment of LSCD With DM NCT05909735 | University of Minnesota | Phase 1 |
| Completed | CDL Validation Study NCT05461469 | Occyo GmbH | — |
| Recruiting | Labial Mucosal Epithelium Grafting for Corneal Limbus Substitution NCT04995926 | The S.N. Fyodorov Eye Microsurgery State Institution | N/A |
| Active Not Recruiting | Stem Cell Therapy for Limbal Stem Cell Deficiency NCT03957954 | University of California, Los Angeles | Phase 1 |
| Unknown | The Effects of Allogeneic SLET NCT04021134 | National Taiwan University Hospital | — |
| Unknown | The Effects of Autologous SLET NCT04021875 | National Taiwan University Hospital | — |
| Unknown | Allogeneic ABCB5-positive Limbal Stem Cells for Treatment of LSCD NCT03549299 | RHEACELL GmbH & Co. KG | Phase 1 / Phase 2 |
| Completed | Multiple Noninvasive Examination Modality to Evaluate the Severity of Ocular Surface Disorders NCT03594370 | National Taiwan University Hospital | — |
| Completed | Corneal Epithelial Allograft From Living-related Donor for LSCD NCT03217435 | Chunxiao Wang | N/A |
| Unknown | Corneal Epithelial Autograft for LSCD NCT03217487 | Chunxiao Wang | N/A |
| Unknown | Transplantation of Autologous Oral Mucosal Epithelial Stem Cell Sheet for Treating Limbal Stem Cell Deficiency NCT03015779 | He Eye Hospital | Phase 1 / Phase 2 |
| Completed | Limbal Stem Cell Deficiency (LSCD) Treatment With Cultivated Stem Cell (CALEC) Graft NCT02592330 | Massachusetts Eye and Ear Infirmary | Phase 1 / Phase 2 |
| Unknown | Cultivated Autologous Oral Mucosal Epithelial Transplantation NCT03943797 | Chang Gung Memorial Hospital | Phase 1 |
| Completed | Biodegradable Synthetic Scaffold as a Substitute for hAM in Limbal Epithelial Cells Transplant in LSCD Patient NCT02568527 | Virender S Sangwan, MBBS, MS | N/A |
| Completed | Autologous Oral Mucosa Transplantation for Limbal Stem Cell Deficiency NCT03226015 | Klinikum Chemnitz gGmbH | — |
| Completed | Limbal Epithelial Stem Cell Transplantation: a Phase II Multicenter Trial NCT02318485 | University Hospital, Antwerp | Phase 2 |
| Terminated | ABCB5 as a Prognostic Marker in Survival of Cultivated Limbal Stem Cell Transplantation NCT02579993 | Instituto de Oftalmología Fundación Conde de Valenciana | N/A |
| Available | Clinical Trial on the Effect of Autologous Oral Mucosal Epithelial Sheet Transplantation NCT02149732 | Seoul National University Hospital | — |
| Completed | Transplantation of Autologous Oral Mucosal Epithelial Sheets for Limbal Stem-cell Deficiency NCT02415218 | Siriraj Hospital | Phase 1 / Phase 2 |
| Recruiting | Autologous Cultured Corneal Epithelium (CECA) for the Treatment of Limbal Stem Cell Deficiency NCT01756365 | CHU de Quebec-Universite Laval | N/A |
| Unknown | Cultivated Stem Cell Transplantation for the Treatment of Limbal Stem Cell Deficiency NCT00845117 | Ethisch Comité UZ Antwerpen | Phase 1 / Phase 2 |
| Completed | Autologous Transplantation of Cultivated Limbal Stem Cells on Amniotic Membrane in Limbal Stem Cell Deficiency NCT00736307 | Royan Institute | Phase 1 / Phase 2 |
| Withdrawn | Multicenter Study of CAOMECS Transplantation to Patients With Total Limbal Stem Cell Deficiency NCT01489501 | CellSeed France S.A.R.L. | Phase 3 |